Immunotherapy for Infectious Diseases Conference
- November 13, 2018
Infectious diseases are amongst the top 10 causes of death worldwide, as reported by World Health Organization. Global antimicrobial resistance, emerging and re-emerging infectious diseases, few antibiotics in development pipeline and infections caused by overuse of antibiotics are all issues that have raised serious concerns across the globe. Immunotherapy represents a new promising approach to treating life-threatening infections while decreasing the risk of damaging microbiome and potentially circumventing the drug resistance issues. Most novel concepts come from academia whereas the biotechnology/pharmaceutical industry has made recent progress in bring immunotherapy for infectious disease to the clinic. We are therefore organizing a conference in the interphase between academia and industry. Our ambition is to provide a forum where various immunotherapeutic strategies can be discussed and lead to exchange of ideas and cross-disciplinary collaborations.
We have assembled an exciting program for the conference that features keynote seminars from international experts in the field, talks from both academia and industry as well as presentations on novel therapeutic techniques for immunotherapy. The conference program also contains poster sessions.
The conference will feature sessions on:
- Antibody based drug development
- Immunotherapy against viral infections
- Immunotherapy against bacterial infections
- Immunotherapy against emerging infections
- Emerging novel therapeutics showcase
- Challenges of immunotherapy against infectious diseases
The Immunotherapy for Infectious Diseases conference will be held on November 12-14, 2018 at Hotel Galvez, Galveston, TX, USA. Participation is limited to 150 attendees. Abstract submission deadline is October 15, 2018. Please check the abstract guidelines page for more information.
2024 Seawall Blvd., Galveston, TX 77550
Srishtee Arora, Ph.D.